pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 17·1 min read
save

Murder suspect plans psychiatric defense in killing of UnitedHealthcare CEO

Jun 17, 2026·read at STAT ↗Negative

Luigi Mangione has told the court he will rely on a psychiatric defense, arguing that he was suffering from extreme emotional disturbance when he shot UnitedHealthcare chief Brian Thompson.

If a jury accepts that defense, Mangione could be convicted of manslaughter rather than murder, limiting any sentence to a maximum of 25 years in prison instead of a potential life term. The emotional disturbance claim is not available in his parallel federal case, where a life sentence remains possible.

New York Judge Gregory Carro announced the defense strategy after a secret hearing requested by Mangione’s lawyers. The judge said a transcript and related records will be unsealed once redacted, and noted the defense was first raised in a sealed letter filed last year.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Luigi Mangione will assert psychiatric defense in murder case in UnitedHealthcare CEO’s killing”

read at STAT ↗
887 words · retrieved Jun 17
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LILLY
topics
AdComMajor DepressionVaccine

related stories

  • Jun 18What’s next for GLP-1 weight loss drugs?STAT
  • Jun 17STAT+: DOJ’s swift win in OhioHealth case should have hospitals studying their contracts, experts saySTAT
  • Jun 17STAT+: FDA appears open to Moderna’s flu vaccine ahead of adcommSTAT
  • 13h agoTScan axes 75% of workforce, prioritizes solid tumor programBioSpace
  • Aug 26Capricor’s DMD therapy still alive, Merck/Moderna’s cancer vax shines, FDA’s future revealedBioSpace